DATASHEET
Host:
Rabbit
Target Protein:
HTRA2
Immunogen Range:
355-458/458
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
27429
Swiss Prot:
O43464
Source:
KLH conjugated synthetic peptide derived from human HtrA2
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
Background:
Serine protease that shows proteolytic activity against a non-specific substrate beta-casein. Promotes or induces cell death either by direct binding to and inhibition of BIRC proteins(also called inhibitor of apoptosis proteins, IAPs), leading to an increase in caspase activity, or by a BIRC inhibition-independent, caspase-independent and serine protease activity-dependent mechanism. Isoform 2 seems to be proteolytically inactive. [CATALYTIC ACTIVITY] Cleavage of non-polar aliphatic amino-acids at the P1 position, with a preference for Val, Ile and Met. At the P2 and P3 positions, Arg is selected most strongly with a secondary preference for other hydrophilic residues. [SUBUNIT] Homotrimer. Interacts with MXI2. The mature protein, but not the precursor, binds to BIRC2, BIRC3 and XIAP.
VALIDATION IMAGES
Lane 1: LOVO lysates; Lane 2: TT lysates probed with HTRA2 Polyclonal Antibody, Unconjugated (bs-1271R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Tissue/cell: Rat Kidney tissue; 4% Paraformaldehyde-fixed and paraffin-embedded; Antigen retrieval: citrate buffer (0.01M, pH 6.0), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum) at 37℃ for 20 min; Incubation: HTRA2/Omi Polyclonal Antibody, Unconjugated (bs-1271R) 1:200, overnight at 4°C, followed by incubation with conjugated secondary antibody and DAB staining
Lane 1: Mouse Cerebrum lysates; Lane 2: Rat Cerebrum lysates; Lane 3: Human Hela cell lysates; Lane 4: Human U-2OS cell lysates; Lane 5: Human HT1080 cell lysates; Lane 6: Human Jurkat cell lysates probed with HtrA2/Omi Polyclonal Antibody, Unconjugated (bs-1271R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.